Bioterrorism and Public Health: An Internet Resource Guide

by ; ; ;
Format: Paperback
Pub. Date: 2002-02-01
Publisher(s): Physicians Desk Reference Inc
List Price: $29.95

Rent Textbook

Select for Price
There was a problem. Please try again later.

New Textbook

We're Sorry
Sold Out

Used Textbook

We're Sorry
Sold Out

eTextbook

We're Sorry
Not Available

This item is being sold by an Individual Seller and will not ship from the Online Bookstore's warehouse. The Seller must confirm the order within two business days. If the Seller refuses to sell or fails to confirm within this time frame, then the order is cancelled.

Please be sure to read the Description offered by the Seller.

Summary

This unique reference directs readers to the most useful web sites on biological and chemical agents. It will help government officials, cl inicians, public health professionals, and consumers alike quickly zer o in on the best sources of accurate and reliable information. The gu ide covers a range of web sites that addresses the information needs o f many different groups. For example, clinicians are alerted to which sites provide guidelines on treatments and vaccinations. Federal, lo cal, and state officials involved in either preventing bioterrorism at tacks or responding to attacks will find a multitude of sites to aid i n policy development. In addition, Bioterrorism & Public Health provi des legislators, prosecutors, and attorneys the most useful sites for their work on legal issues surrounding bioterrorism. And mental healt h professionals will discover resources to aid them in their counselin g of patients with post-traumatic stress disorder. Save hours of time searching the I

Table of Contents

Introduction
1(2)
Getting Online
3(132)
The Science of Bioterrorism: HHS Preparedness
Director, Office of Public Health Preparedness, Department of Health and Human Services
9(14)
D.A. Henderson
Metropolitan Medical Response System
10(1)
National Disaster Medical System (NDMS)
11(1)
National Pharmaceutical Stockpile
11(2)
CDC Surveillance and Prevention Efforts
13(1)
CDC and ATSDR Remediation Support Activities
14(2)
Food and Drug Administration
16(1)
National Institutes of Health
17(2)
Conclusion
19(4)
Frequently Asked Questions: Bioterrorism Concerns After September 11
The Johns Hopkins Center for Civilian Biodefense Strategies
23(4)
Funding for Bioterrorism Preparedness and Response
Resolution, U.S. Congress
27(4)
Bioterrorism Public Health Advisories and Guidelines
Centers for Disease Control and Prevention (CDC)
31(1)
FAQs about Anthrax
31(27)
Definition
31(1)
History
32(1)
Signs and Symptoms
32(2)
Exposure
34(3)
Testing
37(2)
Diagnosis
39(2)
Preventive Therapy
41(1)
Treatment
42(4)
Vaccine
46(1)
Reporting
47(1)
Response
48(3)
Laboratory Safety
51(1)
Worker Safety
51(5)
Sources
56(2)
Biological and Chemical Terrorism: Strategic Plan for Preparedness and Response
58(21)
Recommendations of the CDC Strategic Planning Workgroup
59(1)
Introduction
59(2)
U.S. Vulnerability to Biological and Chemical Terrorism
61(1)
Overt Versus Covert Terrorist Attacks
61(1)
Focusing Preparedness Activities
62(1)
Key Focus Areas
63(3)
Partnerships and Implementation
66(1)
Recommendations
66(1)
Conclusion
67(12)
Children and Anthrax: A Fact Sheet for Clinicians
79(5)
Vaccination
80(1)
Prophylaxis
80(1)
Drug Recommendations for Pediatric Anthrax Cases
81(3)
Considerations for Distinguishing Influenza-Like Illness from Inhalational Anthrax
84(5)
Epidemiologic Considerations
84(1)
Clinical Considerations
85(1)
Testing
85(4)
Epidemiology of Bioterrorism
89(5)
Differential Diagnosis
89(1)
Epidemiologic Approach
90(1)
Epidemic Curve
90(1)
Epidemiologic Clues
91(1)
Recommendations for Preparedness
92(2)
Health Advisory: How to Recognize and Handle a Suspicious Package or Envelope
94(3)
Identifying Suspicious Packages and Envelopes
94(3)
Health Advisory: Recommendations for Protecting Workers from Exposure to Bacillus anthracis in Work Sites Where Mail Is Handled or Processed
97(5)
Health Advisory: Use of Ciprofloxacin or Doxycycline for Postexposure Prophylaxis for Prevention of Inhalation Anthrax
102(1)
Interim Guidelines for Investigation of and Response to Bacillus Anthracis Exposures
103(5)
Environmental Sampling
103(1)
Closing Facilities
104(1)
Environmental Sampling
105(1)
Nasal Swab Cultures
105(1)
Antimicrobial Prophylaxis
106(1)
Closing a Facility
107(1)
Protecting Investigators Performing Environmental Sampling for Bacillus anthracis: Personal Protective Equipment
108(3)
Recognition of Illness Associated with the Intentional Release of a Biologic Agent
111(6)
Healthcare Providers
111(2)
Clinical Laboratory Personnel
113(1)
Infection-Control Professionals
114(1)
State Health Departments
114(3)
Updated Recommendations for Antimicrobial Prophylaxis among Asymptomatic Pregnant Women after Exposure to Bacillus anthracis
117(2)
Use of Onsite Technologies for Rapidly Assessing Environmental Bacillus Anthracis Contamination on Surfaces in Buildings
119(2)
Vaccinia (Smallpox) Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001
121(14)
Routine Nonemergency Vaccine Use
121(1)
Routine Nonemergency Revaccination
122(1)
Side Effects and Adverse Reactions
122(1)
Treatment for Vaccinia Vaccine Complications
122(1)
Other Treatment Options for Vaccinia Vaccine Complications
123(1)
Consultation Regarding Complications of Vaccinia Vaccine
123(2)
Major Reaction
125(1)
Equivocal Reaction
126(1)
Surveillance
127(1)
Prerelease Vaccination
128(1)
Postrelease Vaccination
128(2)
Infection Control Measures
130(2)
Vaccinia Immunoglobulin for Prophylaxis and Treatment of Adverse Reactions during a Smallpox Emergency
132(3)
News, Communications, and Internet Research
135(12)
News Sources and Bulletins
135(7)
Conferences and Symposia
142(3)
Literature Searches and Online Libraries
145(1)
Topical Search Tools
145(2)
General Resource Sites
147(12)
Bioterrorism
147(5)
Chemical Warfare
152(1)
Weapons of Mass Destruction
153(1)
Agricultural Biowarfare
154(3)
Waterborne Biowarfare
157(2)
Public Policy, Preparedness, and Response
159(18)
Public Policy Guidelines, Conventions, and Analysis
159(2)
Public Preparedness and Response
161(12)
Legislation and Legal Issues
173(4)
Clinical Resources on Bioterrorism
177(10)
Guidelines and Consensus Statements
177(4)
Diagnostics
181(2)
Therapeutics
183(2)
Immunization and Vaccines
185(2)
Health and Safety Guidelines
187(4)
Diseases
191(18)
General Resources
191(1)
Anthrax
191(5)
Botulism
196(3)
Brucellosis
199(1)
Plague
199(2)
Q Fever
201(1)
Smallpox
202(3)
Tularemia
205(1)
Viral Hemorrhagic Fever
206(3)
Hazardous Materials
209(4)
Detection
213(2)
Dcontamination
215(2)
Psychosocial Issues
217(6)
Guidelines and Resources
217(3)
Post-Traumatic Stress Disorder
220(3)
Agencies, Organizations, and Centers
223(40)
U.S. Government Agencies and Programs
223(10)
U.S. Military Agencies and Programs
233(9)
Associations
242(10)
Research and Policy Centers
252(7)
International Agencies
259(4)
Public Health Resources on the Internet
263(26)
General Resources
263(1)
Journals
263(4)
Hotlines and Altering Services
267(2)
Online Texts and Tutorials
269(4)
Mailing Lists and Discussion Forums
273(1)
Education and Training Resources
274(6)
Reference Resources
280(4)
Regional Resources
284(5)
Glossaries
289(2)
Web Site and Topical Index
291

An electronic version of this book is available through VitalSource.

This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.

By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.

A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.

Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.

Please view the compatibility matrix prior to purchase.